Download PDF
Semin Neurol 2006; 26(5): 507-514
DOI: 10.1055/s-2006-951623
Published 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Heredity, Genes, and Headache

Nancy R. Barbas1 , Erica A. Schuyler1
  • 1Department of Neurology, University of Michigan and VA Ann Arbor Healthcare System, Ann Arbor, Michigan
Further Information

Publication History

Publication Date:
17 October 2006 (online)

    Permissions and Reprints

ABSTRACT

It is well recognized that headache, and especially migraine, runs in families. Recent studies into the heritability of primary headache subtypes, migraine, cluster and tension headache, and conditions in which headache is a prominent feature, such as the mitochondrial disease, mitochondrial encephalopathy, lactic acidosis, and strokelike episodes, and the arteriopathy, cerebral autosomal-dominant arteriopathy with subcortical infarctions and leukoencephalopathy, are improving our understanding of the genetic contribution to headache. Studies of the rare familial hemiplegic migraine are leading to advances in understanding the pathophysiological mechanisms of the more common migraine types. Current knowledge of hereditary and genetic features of headache subtypes is reviewed and the implications for understanding the pathophysiology of migraine are discussed.

KEYWORDS

Headache - migraine - familial hemiplegic migraine - genetics

REFERENCES

  • 1 Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.  Cephalalgia. 1988;  8(suppl 7) 1-96
    CrossrefPubMedGoogle Scholar
  • 2 Kors E E, Vanmolkot K R, Haan J, Frants R R, van den Maagdenberg A M, Ferrari M D. Recent findings in headache genetics.  Curr Opin Neurol. 2004;  17 283-288
    CrossrefPubMedGoogle Scholar
  • 3 Wessman M, Kaunisto M A, Kallela M, Palotie A. The molecular genetics of migraine.  Ann Med. 2004;  36 462-473
    PubMedGoogle Scholar
  • 4 Ophoff R A, Terwindt G M, Vergouwe M N et al.. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2 + channel gene CACNL1A4.  Cell. 1996;  87 543-552
    CrossrefPubMedGoogle Scholar
  • 5 De Fusco M, Marconi R, Silvestri L et al.. Haploinsufficiency of ATP1A2 encoding the Na + /K + pump alpha2 subunit associated with familial hemiplegic migraine type 2.  Nat Genet. 2003;  33 192-196
    CrossrefPubMedGoogle Scholar
  • 6 Marconi R, De Fusco M, Aridon P et al.. Familial hemiplegic migraine type 2 is linked to 0.9Mb region on chromosome 1q23.  Ann Neurol. 2003;  53 376-381
    CrossrefPubMedGoogle Scholar
  • 7 Bigal M E, Liberman J N, Lipton R B. Obesity and migraine: a population study.  Neurology. 2006;  66 545-550
    CrossrefPubMedGoogle Scholar
  • 8 Lipton R B, Stewart W F, Diamond S, Diamond M L, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II.  Headache. 2001;  41 646-657
    CrossrefPubMedGoogle Scholar
  • 9 Stewart W F, Lipton R B, Celentano D D, Reed M L. Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors.  JAMA. 1992;  267 64-69
    CrossrefPubMedGoogle Scholar
  • 10 Ferrari M D. Migraine.  Lancet. 1998;  351 1043-1051
    CrossrefPubMedGoogle Scholar
  • 11 Lipton R B, Bigal M E. The epidemiology of migraine.  Am J Med. 2005;  118(suppl 1) 3S-10S
    PubMedGoogle Scholar
  • 12 Ferrari M. Heritability of migraine.  Neurology. 2003;  60 S15-S20
    CrossrefPubMedGoogle Scholar
  • 13 Headache Classification Subcommittee of the International Headache Society . The International Classification of Headache Disorders: 2nd edition.  Cephalalgia. 2004;  24(suppl 1) 9-160
    CrossrefPubMedGoogle Scholar
  • 14 Russell M B, Rasmussen B K, Thorvaldsen P, Olesen J. Prevalence and sex-ratio of the subtypes of migraine.  Int J Epidemiol. 1995;  24 612-618
    CrossrefPubMedGoogle Scholar
  • 15 Stewart W F, Staffa J, Lipton R B, Ottman R. Familial risk of migraine: a population-based study.  Ann Neurol. 1997;  41 166-172
    CrossrefPubMedGoogle Scholar
  • 16 Russell M B, Olesen J. Increased familial risk and evidence of genetic factor in migraine.  BMJ. 1995;  311 541-544
    PubMedGoogle Scholar
  • 17 Gervil M, Ulrich V, Kyvik K O, Olesen J, Russell M B. Migraine without aura: a population-based twin study.  Ann Neurol. 1999;  46 606-611
    CrossrefPubMedGoogle Scholar
  • 18 Ulrich V, Gervil M, Kyvik K O, Olesen J, Russell M B. Evidence of a genetic factor in migraine with aura: a population-based Danish twin study.  Ann Neurol. 1999;  45 242-246
    CrossrefPubMedGoogle Scholar
  • 19 Cader Z M, Noble-Topham S, Dyment D A et al.. Significant linkage to migraine with aura on chromosome 11q24.  Hum Mol Genet. 2003;  12 2511-2517
    CrossrefPubMedGoogle Scholar
  • 20 Carlsson A, Forsgren L, Nylander P O et al.. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-p21.1  Neurology. 2002;  59 1804-1807
    CrossrefPubMedGoogle Scholar
  • 21 Soragna D, Vettori A, Carraro G et al.. A locus for migraine without aura maps on chromosome 14q21.2-q22.3  Am J Hum Genet. 2003;  72 161-167
    CrossrefPubMedGoogle Scholar
  • 22 Wessman M, Kallela M, Kaunisto M A et al.. A susceptibility locus for migraine with aura, on chromosome 4q24.  Am J Hum Genet. 2002;  70 652-662
    CrossrefPubMedGoogle Scholar
  • 23 Lea R A, Shepherd A G, Curtain R P et al.. A typical migraine susceptibility region localizes to chromosome 1q31.  Neurogenetics. 2002;  4 17-22
    CrossrefPubMedGoogle Scholar
  • 24 Nyholt D R, Curtain R P, Griffiths L R. Familial typical migraine: significant linkage and localization of a gene to Xq24-28.  Hum Genet. 2000;  107 18-23
    PubMedGoogle Scholar
  • 25 Johnson M P, Lea R A, Curtain R P, MacMillan J C, Griffiths L R. An investigation of the 5-HT2C receptor gene as a migraine candidate gene.  Am J Med Genet B Neuropsychiatr Genet. 2003;  117 86-89
    PubMedGoogle Scholar
  • 26 Juhasz G, Zsombok T, Laszik A et al.. Association analysis of 5-HTTLPR variants, 5-HT2a receptor gene 102T/C polymorphism and migraine.  J Neurogenet. 2003;  17 231-240
    PubMedGoogle Scholar
  • 27 Mochi M, Cevoli S, Cortelli P et al.. A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes.  Neurol Sci. 2003;  23 301-305
    CrossrefPubMedGoogle Scholar
  • 28 Peroutka S J, Wilhoit T, Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles.  Neurology. 1997;  49 201-206
    PubMedGoogle Scholar
  • 29 Kara I, Sazci A, Ergul E, Kaya G, Kilic G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk.  Brain Res Mol Brain Res. 2003;  111 84-90
    PubMedGoogle Scholar
  • 30 Kusumi M, Ishizaki K, Kowa H et al.. Glutathione S-transferase polymorphisms: susceptibility to migraine without aura.  Eur Neurol. 2003;  49 218-222
    CrossrefPubMedGoogle Scholar
  • 31 Mochi M, Cevoli S, Cortelli P et al.. Investigation of an LDLR gene polymorphism (19p13.2) in susceptibility to migraine without aura.  J Neurol Sci. 2003;  213 7-10
    CrossrefPubMedGoogle Scholar
  • 32 Ducros A, Denier C, Joutel A et al.. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel.  N Engl J Med. 2001;  345 17-24
    PubMedGoogle Scholar
  • 33 Ophoff R A, van Eijk R, Sandkuijl L A et al.. Genetic heterogeneity of familial hemiplegic migraine.  Genomics. 1994;  22 21-26
    CrossrefPubMedGoogle Scholar
  • 34 Joutel A, Bousser M G, Biousse V et al.. A gene for familial hemiplegic migraine maps to chromosome 19.  Nat Genet. 1993;  5 40-45
    CrossrefPubMedGoogle Scholar
  • 35 Alonso I, Barros J, Tuna A et al.. Phenotypes of spinocerebellar ataxia type 6 and familial hemiplegic migraine caused by a unique CACNA1A missense mutation in patients from a large family.  Arch Neurol. 2003;  60 610-614
    CrossrefPubMedGoogle Scholar
  • 36 Kors E E, Haan J, Giffin N J et al.. Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine.  Arch Neurol. 2003;  60 684-688
    CrossrefPubMedGoogle Scholar
  • 37 Jurkat-Rott K, Freilinger T, Dreier J P et al.. Variability of familial hemiplegic migraine with novel A1A2 Na + /K + -ATPase variants.  Neurology. 2004;  62 1857-1861
    CrossrefPubMedGoogle Scholar
  • 38 Kaunisto M A, Harno H, Vanmolkot K R et al.. A novel missense ATP1A2 mutation in a Finnish family with familial hemiplegic migraine type 2.  Neurogenetics. 2004;  5 141-146
    CrossrefPubMedGoogle Scholar
  • 39 Riant F, De Fusco M, Aridon P et al.. ATP1A2 mutations in 11 families with familial hemiplegic migraine.  Hum Mutat. 2005;  26 281
    PubMedGoogle Scholar
  • 40 Spadaro M, Ursu S, Lehmann-Horn F et al.. A G301R Na + /K + -ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs.  Neurogenetics. 2004;  5 177-185
    CrossrefPubMedGoogle Scholar
  • 41 Vanmolkot K R, Kors E E, Hottenga J J et al.. Novel mutations in the Na + , K + -ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions.  Ann Neurol. 2003;  54 360-366
    CrossrefPubMedGoogle Scholar
  • 42 Vanmolkot K R, Kors E E, Turk U et al.. Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine.  Eur J Hum Genet. 2006;  14 555-560
    PubMedGoogle Scholar
  • 43 Koenderink J B, Zifarelli G, Qiu L Y et al.. Na,K-ATPase mutations in familial hemiplegic migraine lead to functional inactivation.  Biochim Biophys Acta. 2005;  1669 61-68
    PubMedGoogle Scholar
  • 44 Dichgans M, Freilinger T, Eckstein G et al.. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine.  Lancet. 2005;  366 371-377
    CrossrefPubMedGoogle Scholar
  • 45 Goadsby P J, Lipton R B, Ferrari M D. Migraine: current understanding and treatment.  N Engl J Med. 2002;  346 257-270
    CrossrefPubMedGoogle Scholar
  • 46 Pietrobon D, Striessnig J. Neurobiology of migraine.  Nat Rev Neurosci. 2003;  4 386-398
    CrossrefPubMedGoogle Scholar
  • 47 Leao A AP. Spreading depression of activity in cerebral cortex.  J Neurophysiol. 1944;  7 359-390
    PubMedGoogle Scholar
  • 48 Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz M A. Suppression of cortical spreading depression in migraine prophylaxis.  Ann Neurol. 2006;  59 652-661
    CrossrefPubMedGoogle Scholar
  • 49 Bowyer S M, Aurora K S, Moran J E, Tepley N, Welch K M. Magnetoencephalographic fields from patients with spontaneous and induced migraine aura.  Ann Neurol. 2001;  50 582-587
    CrossrefPubMedGoogle Scholar
  • 50 Cutrer F M, Sorensen A G, Weisskoff R M et al.. Perfusion-weighted imaging defects during spontaneous migrainous aura.  Ann Neurol. 1998;  43 25-31
    CrossrefPubMedGoogle Scholar
  • 51 Hadjikhani N, Sanchez Del Rio M, Wu O et al.. Mechanisms of migraine aura revealed by functional MRI in human visual cortex.  Proc Natl Acad Sci USA. 2001;  98 4687-4692
    CrossrefPubMedGoogle Scholar
  • 52 Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory.  Brain. 1994;  117 199-210
    CrossrefPubMedGoogle Scholar
  • 53 Bolay H, Reuter U, Dunn A K, Huang Z, Boas D A, Moskowitz M A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.  Nat Med. 2002;  8 136-142
    CrossrefPubMedGoogle Scholar
  • 54 Goadsby P J. Migraine, aura, and cortical spreading depression: why are we still talking about it?.  Ann Neurol. 2001;  49 4-6
    CrossrefPubMedGoogle Scholar
  • 55 Weiller C, May A, Limmroth V et al.. Brain stem activation in spontaneous human migraine attacks.  Nat Med. 1995;  1 658-660
    CrossrefPubMedGoogle Scholar
  • 56 Knight Y E, Bartsch T, Kaube H, Goadsby P J. P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine?.  J Neurosci. 2002;  22 RC213
    PubMedGoogle Scholar
  • 57 Ayata C, Shimizu-Sasamata M, Lo E H, Noebels J L, Moskowitz M A. Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P/Q type calcium channels.  Neuroscience. 2000;  95 639-645
    PubMedGoogle Scholar
  • 58 Caddick S J, Wang C, Fletcher C F, Jenkins N A, Copeland N G, Hosford D A. Excitatory but not inhibitory synaptic transmission is reduced in lethargic (Cacnb4(lh)) and tottering (Cacna1atg) mouse thalami.  J Neurophysiol. 1999;  81 2066-2074
    PubMedGoogle Scholar
  • 59 van den Maagdenberg A M, Pietrobon D, Pizzorusso T et al.. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression.  Neuron. 2004;  41 701-710
    CrossrefPubMedGoogle Scholar
  • 60 Ikeda K, Onaka T, Yamakado M et al.. Degeneration of the amygdala/piriform cortex and enhanced fear/anxiety behaviors in sodium pump alpha2 subunit (Atp1a2)-deficient mice.  J Neurosci. 2003;  23 4667-4676
    PubMedGoogle Scholar
  • 61 James P F, Grupp I L, Grupp G et al.. Identification of a specific role for the Na,K-ATPase alpha 2 isoform as a regulator of calcium in the heart.  Mol Cell. 1999;  3 555-563
    CrossrefPubMedGoogle Scholar
  • 62 Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.  Nature. 1990;  348 651-653
    CrossrefPubMedGoogle Scholar
  • 63 Kobayashi Y, Momoi M Y, Tominaga K et al.. A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes).  Biochem Biophys Res Commun. 1990;  173 816-822
    CrossrefPubMedGoogle Scholar
  • 64 Hirano M, Pavlakis S G. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts.  J Child Neurol. 1994;  9 4-13
    CrossrefPubMedGoogle Scholar
  • 65 Meschia J F, Brott T G, Brown Jr R D. Genetics of cerebrovascular disorders.  Mayo Clin Proc. 2005;  80 122-132
    CrossrefPubMedGoogle Scholar
  • 66 Ciafaloni E, Ricci E, Shanske S et al.. MELAS: clinical features, biochemistry, and molecular genetics.  Ann Neurol. 1992;  31 391-398
    CrossrefPubMedGoogle Scholar
  • 67 Cupini L M, Massa R, Floris R et al.. Migraine-like disorder segregating with mtDNA 14484 Leber hereditary optic neuropathy mutation.  Neurology. 2003;  60 717-719
    PubMedGoogle Scholar
  • 68 Boles R G, Adams K, Ito M, Li B U. Maternal inheritance in cyclic vomiting syndrome with neuromuscular disease.  Am J Med Genet A. 2003;  120 474-482
    PubMedGoogle Scholar
  • 69 Haan J, Terwindt G M, Maassen J A, Hart L M, Frants R R, Ferrari M D. Search for mitochondrial DNA mutations in migraine subgroups.  Cephalalgia. 1999;  19 20-22
    CrossrefPubMedGoogle Scholar
  • 70 Montagna P, Sacquegna T, Martinelli P et al.. Mitochondrial abnormalities in migraine: preliminary findings.  Headache. 1988;  28 477-480
    CrossrefPubMedGoogle Scholar
  • 71 Sangiorgi S, Mochi M, Riva R et al.. Abnormal platelet mitochondrial function in patients affected by migraine with and without aura.  Cephalalgia. 1994;  14 21-23
    CrossrefPubMedGoogle Scholar
  • 72 Welch K M, Ramadan N M. Mitochondria, magnesium and migraine.  J Neurol Sci. 1995;  134 9-14
    CrossrefPubMedGoogle Scholar
  • 73 Barbiroli B, Montagna P, Cortelli P et al.. Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura.  Neurology. 1992;  42 1209-1214
    PubMedGoogle Scholar
  • 74 Eleff S M, Barker P B, Blackband S J et al.. Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine.  Ann Neurol. 1990;  27 626-630
    CrossrefPubMedGoogle Scholar
  • 75 Dichgans M, Mayer M, Uttner I et al.. The phenotypic spectrum of CADASIL: clinical findings in 102 cases.  Ann Neurol. 1998;  44 731-739
    CrossrefPubMedGoogle Scholar
  • 76 Joutel A, Corpechot C, Ducros A et al.. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.  Nature. 1996;  383 707-710
    CrossrefPubMedGoogle Scholar
  • 77 de Freitas G R, Miklossy J, Christen-Zach S, Reichhart M, Bogousslavsky J A. CADASIL case with normal skin biopsy and without mutations in exons 3 and 4 of the Notch3 gene.  J Neurol Sci. 2001;  193 43-47
    CrossrefPubMedGoogle Scholar
  • 78 Joutel A, Andreux F, Gaulis S et al.. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients.  J Clin Invest. 2000;  105 597-605
    PubMedGoogle Scholar
  • 79 Joutel A, Favrole P, Labauge P et al.. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis.  Lancet. 2001;  358 2049-2051
    CrossrefPubMedGoogle Scholar
  • 80 Lesnik Oberstein S A, van Duinen S G, van den Boom R et al.. Evaluation of diagnostic NOTCH3 immunostaining in CADASIL.  Acta Neuropathol (Berl). 2003;  106 107-111
    CrossrefPubMedGoogle Scholar
  • 81 Mayer M, Straube A, Bruening R et al.. Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL.  J Neurol. 1999;  246 526-532
    PubMedGoogle Scholar
  • 82 Walsh J S, Perniciaro C, Meschia J F. CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy): diagnostic skin biopsy changes determined by electron microscopy.  J Am Acad Dermatol. 2000;  43 1125-1127
    CrossrefPubMedGoogle Scholar
  • 83 Markus H S, Martin R J, Simpson M A et al.. Diagnostic strategies in CADASIL.  Neurology. 2002;  59 1134-1138
    PubMedGoogle Scholar
  • 84 Federico A, Bianchi S, Dotti M T. The spectrum of mutations for CADASIL diagnosis.  Neurol Sci. 2005;  26 117-124
    CrossrefPubMedGoogle Scholar
  • 85 Russell M B. Epidemiology and genetics of cluster headache.  Lancet Neurol. 2004;  3 279-283
    PubMedGoogle Scholar
  • 86 D'Alessandro R, Gamberini G, Benassi G, Morganti G, Cortelli P, Lugaresi E. Cluster headache in the Republic of San Marino.  Cephalalgia. 1986;  6 159-162
    CrossrefPubMedGoogle Scholar
  • 87 Ekbom K, Ahlborg B, Schele R. Prevalence of migraine and cluster headache in Swedish men of 18.  Headache. 1978;  18 9-19
    CrossrefPubMedGoogle Scholar
  • 88 Sjaastad O, Bakketeig L S. Cluster headache prevalence: Vaga study of headache epidemiology.  Cephalalgia. 2003;  23 528-533
    CrossrefPubMedGoogle Scholar
  • 89 Swanson J W, Yanagihara T, Stang P E et al.. Incidence of cluster headaches: a population-based study in Olmsted County, Minnesota.  Neurology. 1994;  44 433-437
    PubMedGoogle Scholar
  • 90 Tonon C, Guttmann S, Volpini M, Naccarato S, Cortelli P, D'Alessandro R. Prevalence and incidence of cluster headache in the Republic of San Marino.  Neurology. 2002;  58 1407-1409
    PubMedGoogle Scholar
  • 91 Couturier E G, Hering R, Steiner T J. The first report of cluster headache in identical twins.  Neurology. 1991;  41 761
    PubMedGoogle Scholar
  • 92 Eadie M J, Sutherland J M. Migrainous neuralgia.  Med J Aust. 1966;  1 1053-1057
    PubMedGoogle Scholar
  • 93 Roberge C, Bouchard J P, Simard D, Gagne R. Cluster headache in twins.  Neurology. 1992;  42 1255-1256
    PubMedGoogle Scholar
  • 94 Sjaastad O, Salvesen R. Cluster headache: are we only seeing the tip of the iceberg?.  Cephalalgia. 1986;  6 127-129
    PubMedGoogle Scholar
  • 95 Sjaastad O, Shen J M, Stovner L J, Elsas T. Cluster headache in identical twins.  Headache. 1993;  33 214-217
    CrossrefPubMedGoogle Scholar
  • 96 Svensson D, Ekbom K, Pedersen N L, Traff H, Waldenlind E. A note on cluster headache in a population-based twin register.  Cephalalgia. 2003;  23 376-380
    CrossrefPubMedGoogle Scholar
  • 97 Russell M B. Epidemiology and genetics of cluster headache.  Lancet Neurol. 2004;  3 279-283
    PubMedGoogle Scholar
  • 98 Spierings E L, Vincent A J. Familial cluster headache: occurrence in three generations.  Neurology. 1992;  42 1399-1400
    PubMedGoogle Scholar
  • 99 Cortelli P, Zacchini A, Barboni P, Malpassi P, Carelli V, Montagna P. Lack of association between mitochondrial tRNA(Leu(UUR)) point mutation and cluster headache.  Lancet. 1995;  345 1120-1121
    CrossrefPubMedGoogle Scholar
  • 100 Seibel P, Grunewald T, Gundolla A, Diener H C, Reichmann H. Investigation on the mitochondrial transfer RNA(Leu)(UUR) in blood cells from patients with cluster headache.  J Neurol. 1996;  243 305-307
    PubMedGoogle Scholar
  • 101 Shimomura T, Kitano A, Marukawa H et al.. Point mutation in platelet mitochondrial tRNA(Leu(UUR)) in patient with cluster headache.  Lancet. 1994;  344 625
    PubMedGoogle Scholar
  • 102 Haan J, van Vliet J A, Kors E E et al.. No involvement of the calcium channel gene (CACNA1A) in a family with cluster headache.  Cephalalgia. 2001;  21 959-962
    CrossrefPubMedGoogle Scholar
  • 103 Sjostrand C, Giedratis V, Ekbom K, Waldenlind E, Hillert J. CACNA1A gene polymorphisms in cluster headache.  Cephalalgia. 2001;  21 953-958
    CrossrefPubMedGoogle Scholar
  • 104 Sjostrand C, Modin H, Masterman T, Ekbom K, Waldenlind E, Hillert J. Analysis of nitric oxide synthase genes in cluster headache.  Cephalalgia. 2002;  22 758-764
    CrossrefPubMedGoogle Scholar
  • 105 Ulrich V, Gervil M, Olesen J. The relative influence of environment and genes in episodic tension-type headache.  Neurology. 2004;  62 2065-2069
    CrossrefPubMedGoogle Scholar
  • 106 Ostergaard S, Russell M B, Bendtsen L, Olesen J. Comparison of first degree relatives and spouses of people with chronic tension headache.  BMJ. 1997;  314 1092-1093
    PubMedGoogle Scholar

Nancy R BarbasM.D. M.S.W. 

Department of Neurology, University of Michigan

1920 Taubman Center 0316, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0316

      >